Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 11 de 11
Filter
2.
Eur J Gynaecol Oncol ; 35(1): 62-6, 2014.
Article in English | MEDLINE | ID: mdl-24654465

ABSTRACT

PURPOSE: To compare the incidence and severity of acute and chronic hematologic toxicity (HT) in patients treated with three-dimensional conformal radiotherapy (3DCRT) and intensity modulated radiotherapy (IMRT) for curative treatment of cervical cancer and to ascertain the dosimetric parameters of two techniques associated with acute and chronic HT. MATERIALS AND METHODS: A total of 127 patients with cervical cancer receiving concomitant pelvic radiotherapy (RT) and cisplatin were evaluated. Pelvic bone marrow (BM) was contoured for each patient and divided into five sub-regions: lumbosacrum (LS), ilium (IL), lower pelvis (LP), pelvis (P), and whole pelvis (WP). The volume of each BM region receiving 10, 20, 30, and 40 Gy was calculated (V10, -V20, -V30, and -V40). The lowest level of hemoglobin, leukocyte, neutrophil, and platelet counts were obtained during chemoradiotherapy and six months after RT. The nadir values were graded according to Common Terminology Criteria for Adverse Events (version 3.0). RESULTS: Grade 2 or greater acute anemia, leukopenia, neutropenia, thrombocytopenia was observed in 2%, 41.5%, 12% ,and 0% in 3DCRT group and in 27%, 53%, 24.5%, and 4.5% in IMRT group, respectively. Grade 2 or greater chronic anemia, leukopenia, neutropenia, and thrombocytopenia was observed in 11%, 10%, 6%, and 0% in 3DCRT group and in 11%, 9%, 4.5%, and 0% in IMRT group, respectively. LS-V30, 40; IL-V10, 20, 30, 40; LP-V10, 20 ,40; P-V10, 20, 30, 40, and TP-V10, 20, 30, 40 were significantly reduced with IMRT planning compared to 3DCRT planning. Logistic regression analysis of potential predictors showed that none of the dosimetric parameters were significant for predicting acute and chronic HT. CONCLUSION: The present findings showed that IMRT planning reduced irradiated BM volumes compared to 3DCRT planning. However, no difference between the two techniques was observed in terms of acute and chronic HT. Further studies are needed to confirm these results.


Subject(s)
Radiotherapy, Conformal/adverse effects , Radiotherapy, Intensity-Modulated/adverse effects , Uterine Cervical Neoplasms/drug therapy , Uterine Cervical Neoplasms/radiotherapy , Adult , Aged , Anemia/etiology , Antineoplastic Agents/adverse effects , Antineoplastic Agents/therapeutic use , Chemoradiotherapy , Cisplatin/adverse effects , Cisplatin/therapeutic use , Dose-Response Relationship, Radiation , Female , Humans , Leukopenia/etiology , Logistic Models , Middle Aged , Retrospective Studies
3.
Braz J Med Biol Res ; 42(7): 621-8, 2009 Jul.
Article in English | MEDLINE | ID: mdl-19578641

ABSTRACT

The effect of ionizing irradiation on testes and the protective effects of melatonin were investigated by immunohistochemical and electron microscopic methods. Eighty-two adult male Wistar rats were divided into 10 groups. The rats in the irradiated groups were exposed to a sublethal irradiation dose of 8 Gy, either to the total body or abdominopelvic region using a 60Co source at a focus of 80 cm away from the skin in the morning or evening together with vehicle (20% ethanol) or melatonin administered 24 h before (10 mg/kg), immediately before (20 mg/kg) and 24 h after irradiation (10 mg/kg), all ip. Caspace-3 immunoreactivity was increased in the irradiated group compared to control (P < 0.05). Melatonin-treated groups showed less apoptosis as indicated by a considerable decrease in caspace-3 immunoreactivity (P < 0.05). Electron microscopic examination showed that all spermatogenic cells, especially primary spermatocytes, displayed prominent degeneration in the groups submitted to total body and abdominopelvic irradiation. However, melatonin administration considerably inhibited these degenerative changes, especially in rats who received abdominopelvic irradiation. Total body and abdominopelvic irradiation induced identical apoptosis and testicular damage. Chronobiological assessment revealed that biologic rhythm does not alter the inductive effect of irradiation. These data indicate that melatonin protects against total body and abdominopelvic irradiation. Melatonin was more effective in the evening abdominopelvic irradiation and melatonin-treated group than in the total body irradiation and melatonin-treated group.


Subject(s)
Melatonin/therapeutic use , Radiation Injuries, Experimental/prevention & control , Radiation-Protective Agents/therapeutic use , Testis/radiation effects , Animals , Apoptosis , Caspase 3/metabolism , Immunohistochemistry , Male , Melatonin/administration & dosage , Microscopy, Electron, Transmission , Radiation Injuries, Experimental/enzymology , Radiation Injuries, Experimental/pathology , Radiation-Protective Agents/administration & dosage , Rats , Rats, Wistar , Spermatogenesis/drug effects , Spermatogenesis/radiation effects , Testis/drug effects , Testis/pathology , Time Factors
4.
Braz. j. med. biol. res ; 42(7): 621-628, July 2009. ilus, tab
Article in English | LILACS | ID: lil-517792

ABSTRACT

The effect of ionizing irradiation on testes and the protective effects of melatonin were investigated by immunohistochemical and electron microscopic methods. Eighty-two adult male Wistar rats were divided into 10 groups. The rats in the irradiated groups were exposed to a sublethal irradiation dose of 8 Gy, either to the total body or abdominopelvic region using a 60Co source at a focus of 80 cm away from the skin in the morning or evening together with vehicle (20% ethanol) or melatonin administered 24 h before (10 mg/kg), immediately before (20 mg/kg) and 24 h after irradiation (10 mg/kg), all ip. Caspace-3 immunoreactivity was increased in the irradiated group compared to control (P < 0.05). Melatonin-treated groups showed less apoptosis as indicated by a considerable decrease in caspace-3 immunoreactivity (P < 0.05). Electron microscopic examination showed that all spermatogenic cells, especially primary spermatocytes, displayed prominent degeneration in the groups submitted to total body and abdominopelvic irradiation. However, melatonin administration considerably inhibited these degenerative changes, especially in rats who received abdominopelvic irradiation. Total body and abdominopelvic irradiation induced identical apoptosis and testicular damage. Chronobiological assessment revealed that biologic rhythm does not alter the inductive effect of irradiation. These data indicate that melatonin protects against total body and abdominopelvic irradiation. Melatonin was more effective in the evening abdominopelvic irradiation and melatonin-treated group than in the total body irradiation and melatonin-treated group.


Subject(s)
Animals , Male , Rats , Melatonin/therapeutic use , Radiation Injuries, Experimental/prevention & control , Radiation-Protective Agents/therapeutic use , Testis/radiation effects , Apoptosis , /metabolism , Immunohistochemistry , Microscopy, Electron, Transmission , Melatonin/administration & dosage , Rats, Wistar , Radiation Injuries, Experimental/enzymology , Radiation Injuries, Experimental/pathology , Radiation-Protective Agents/administration & dosage , Spermatogenesis/drug effects , Spermatogenesis/radiation effects , Time Factors , Testis/drug effects , Testis/pathology
5.
Scott Med J ; 52(4): 11-4, 2007 Nov.
Article in English | MEDLINE | ID: mdl-18092630

ABSTRACT

INTRODUCTION: The purpose of this study is to report the clinical course and outcome in 7 patients with aggressive fibromatosis. MATERIAL AND METHODS: Between the years 2000 and 2003, 7 patients who were treated with combined modalities were evaluated retrospectively. Patients' demographic information, including age and gender, tumour characteristics, surgical resection, and the use of radiotherapy were recorded and evaluated. RESULTS: The mean patient age was 34 years. The median time to follow-up was 15.5 months. Resection was performed with positive surgical margins in three cases. Three patients were evaluated as inoperable and one patient was treated with debulking surgery. All patients received radiation therapy with a median dose of 51 Gy. At follow-up, three patients had no evidence of disease, three patients were alive with disease, and one patient died 15 days after radiotherapy. CONCLUSION: Local control is the primary problem in aggressive fibromatosis. There is no appropriate treatment for aggressive fibromatosis and the type of treatment depends on tumour characteristics and location as well as patient characteristics.


Subject(s)
Fibromatosis, Abdominal/radiotherapy , Fibromatosis, Aggressive/radiotherapy , Adolescent , Adult , Child, Preschool , Female , Fibromatosis, Abdominal/pathology , Fibromatosis, Abdominal/surgery , Fibromatosis, Aggressive/pathology , Fibromatosis, Aggressive/surgery , Humans , Male , Middle Aged , Retrospective Studies , Treatment Outcome
6.
Braz. j. med. biol. res ; 40(10): 1305-1314, Oct. 2007. graf
Article in English | LILACS | ID: lil-461360

ABSTRACT

We investigated the day-night differences in intestinal oxidative-injury and the inflammatory response following total body (TB) or abdominopelvic (AP) irradiation, and the influence of melatonin administration on tissue injury induced by radiation. Rats (male Wistar, weighing 220-280 g) in the irradiated groups were exposed to a dose of 8 Gy to the TB or AP region in the morning (resting period - 1 h after light onset) or evening (activity span - 13 h after light onset). Vehicle or melatonin was administered immediately before, immediately after and 24 h after irradiation (10, 2.0 and 10 mg/kg, ip, respectively) to the irradiated rats. AP (P < 0.05) and TB (P < 0.05) irradiation applied in the morning caused a significant increase in thiobarbituric acid reactive substance (TBARS) levels. Melatonin treatment in the morning (P < 0.05) or evening (P < 0.05) decreased TBARS levels after TB irradiation. After AP irradiation, melatonin treatment only in the morning caused a significant decrease in TBARS levels (P < 0.05). Although we have confirmed the development of inflammation after radiotherapy by histological findings, neither AP nor TB irradiation caused any marked changes in myeloperoxidase activity in the morning or evening. Our results indicate that oxidative damage is more prominent in rats receiving TB and AP irradiation in the morning and melatonin appears to have beneficial effects on oxidative damage irrespective of the time of administration. Increased neutrophil accumulation indicates that melatonin administration exerts a protective effect on AP irradiation-induced tissue oxidative injury, especially in the morning.


Subject(s)
Animals , Male , Rats , Antioxidants/therapeutic use , Inflammation/prevention & control , Intestine, Small/radiation effects , Melatonin/therapeutic use , Oxidative Stress , Radiation-Protective Agents/therapeutic use , Circadian Rhythm , Oxidative Stress/drug effects , Oxidative Stress/radiation effects , Radiation Injuries, Experimental , Rats, Wistar , Thiobarbituric Acid Reactive Substances/metabolism , Thiobarbituric Acid Reactive Substances/radiation effects , Whole-Body Irradiation
7.
Braz J Med Biol Res ; 40(10): 1305-14, 2007 Oct.
Article in English | MEDLINE | ID: mdl-17713655

ABSTRACT

We investigated the day-night differences in intestinal oxidative-injury and the inflammatory response following total body (TB) or abdominopelvic (AP) irradiation, and the influence of melatonin administration on tissue injury induced by radiation. Rats (male Wistar, weighing 220-280 g) in the irradiated groups were exposed to a dose of 8 Gy to the TB or AP region in the morning (resting period - 1 h after light onset) or evening (activity span - 13 h after light onset). Vehicle or melatonin was administered immediately before, immediately after and 24 h after irradiation (10, 2.0 and 10 mg/kg, ip, respectively) to the irradiated rats. AP (P < 0.05) and TB (P < 0.05) irradiation applied in the morning caused a significant increase in thiobarbituric acid reactive substance (TBARS) levels. Melatonin treatment in the morning (P < 0.05) or evening (P < 0.05) decreased TBARS levels after TB irradiation. After AP irradiation, melatonin treatment only in the morning caused a significant decrease in TBARS levels (P < 0.05). Although we have confirmed the development of inflammation after radiotherapy by histological findings, neither AP nor TB irradiation caused any marked changes in myeloperoxidase activity in the morning or evening. Our results indicate that oxidative damage is more prominent in rats receiving TB and AP irradiation in the morning and melatonin appears to have beneficial effects on oxidative damage irrespective of the time of administration. Increased neutrophil accumulation indicates that melatonin administration exerts a protective effect on AP irradiation-induced tissue oxidative injury, especially in the morning.


Subject(s)
Antioxidants/therapeutic use , Inflammation/prevention & control , Intestine, Small/radiation effects , Melatonin/therapeutic use , Oxidative Stress , Radiation-Protective Agents/therapeutic use , Animals , Circadian Rhythm , Male , Oxidative Stress/drug effects , Oxidative Stress/radiation effects , Radiation Injuries, Experimental , Rats , Rats, Wistar , Thiobarbituric Acid Reactive Substances/metabolism , Thiobarbituric Acid Reactive Substances/radiation effects , Whole-Body Irradiation
8.
Eur J Cancer Care (Engl) ; 16(3): 251-7, 2007 May.
Article in English | MEDLINE | ID: mdl-17508945

ABSTRACT

The aim of this study was to evaluate the efficacy of palliative radiotherapy in patients with advanced cancer in terms of improvement in the quality of life [quality of life questionnaire (QLQ)], and to assess the correlation between the Eastern Cooperative Oncology Group (ECOG) performance status and the European Organization for Research and Treatment of Cancer (EORTC) QLQ-C30 (Turkish version 3.0). A total of 88 patients with advanced malignant disease treated with palliative radiotherapy were included in the study. All patients completed the EORTC QLQ-C30 questionnaire before and after treatment, and the patient performance status during the pre-treatment and post-treatment phase (ECOG 2) was correlated to the EORTC QLQ C-30 with subscales. Most patients (87.5%) had metastatic disease, and the remaining (12.5%) had locally advanced disease. Comparing the patients in terms of performance status, those with a better performance status (

Subject(s)
Neoplasms/psychology , Palliative Care/methods , Surveys and Questionnaires/standards , Adolescent , Adult , Aged , Female , Humans , Male , Middle Aged , Neoplasms/mortality , Neoplasms/radiotherapy , Palliative Care/standards , Quality of Life
9.
Environ Technol ; 26(5): 561-9, 2005 May.
Article in English | MEDLINE | ID: mdl-15974274

ABSTRACT

In this study, sepiolite and natural soil-added sepiolite mixtures were studied to find out whether they can be used as compacted landfill liner, as they are an economic alternative to the other compacted day liners or not. Geotechnical and physico-chemical properties of sepiolite and sepiolite mixtures, containing 25% and 50% natural soil by weight, and compacted at water contents ranging from 35% to 60%, were determined by hydraulic conductivity, leachate analysis, unconfined compression strength, consolidation, volumetric shrinkage and swelling tests. The test results showed that the compacted natural soil-added sepiolite mixtures exhibit lower permeability and swelling properties, and higher compressive strength than pure sepiolite. The overall evaluation of the results has revealed that the natural soil-added sepiolite showed good promise and it can be used as a landfill barrier due to its high capacity of contaminant adsorption.


Subject(s)
Magnesium Silicates/chemistry , Refuse Disposal/methods , Soil Pollutants , Compressive Strength , Materials Testing , Permeability , Solubility , Water Pollution/prevention & control
10.
Biol Trace Elem Res ; 95(1): 65-71, 2003 Oct.
Article in English | MEDLINE | ID: mdl-14555800

ABSTRACT

The effectiveness and success of antituberculosis therapy is mainly measured by its ability to identify the organism in the sputum. In certain cases, available tuberculosis tests are not satisfactory and do not provide enough information on the effectiveness of antituberculosis therapy. Copper (Cu), zinc (Zn), and selenium (Se) are the essential elements that play a crucial role in the immune system. The serum levels of these elements vary in many diseases including tuberculosis. In this study, we investigate whether the serum levels of Cu, Zn, and Se change during antituberculosis therapy. We have included 22 pulmonary tuberculosis cases that were newly diagnosed with positive sputum and 18 healthy subjects. At the beginning and 2 mo after therapy, serum levels of Cu, Zn, and Se were measured by atomic absorption spectrometry. Despite Se and Cu levels not being affected during the treatment, we found that there was a significant increase in the levels of Zn and a decrease in the Cu/Zn ratio. Serum Zn levels and the Cu/Zn ratio could be used as a valuable laboratory tool for the clinicians to assess response to therapy or effectiveness of the ongoing antituberculosis therapy.


Subject(s)
Antitubercular Agents/therapeutic use , Copper/blood , Selenium/blood , Tuberculosis, Pulmonary/blood , Tuberculosis, Pulmonary/drug therapy , Zinc/blood , Adolescent , Adult , Aged , Case-Control Studies , Female , Humans , Male , Middle Aged
SELECTION OF CITATIONS
SEARCH DETAIL
...